TheAIDSReader Members: Login | Register
The AIDS Reader SearchMedica Medline Drugs

Powered by SearchMedica

 
 

Home
 
NEWS
FDA Panel Says Yes to Home HIV Test
http://www.medpagetoday.com - 5/15/12
HIV Linked to Risk of Sudden Cardiac Death (CME/CE)
http://www.medpagetoday.com - 5/15/12
FDA Staff Flags False Results of Home HIV Test
http://www.medpagetoday.com - 5/14/12


 
RESOURCES

RELATED TOPICS

CancerNetwork: 
AIDS-Related Tumors


Consultant Live: 
HIV/AIDS

STDs

Infection

 


OTHER TRUSTED CLINICAL INFORMATION SOURCES


AIDS Education Global Information System (AEGIS)


AIDS Research Alliance


International Association of Physicians in AIDS Care


NIH Centers for Aids Research (CFAR)


Medline Plus: HIV/AIDS


NIH Treatment and Prevention Guidelines


UCSF HIV InSite NewsWatch

 


 
JOURNAL SCAN
Mobile phone text messaging to help patients with HIV infection take their antiretroviral medications every day | Cochrane Summaries
summaries.cochrane.org - 4/18/12
Men and women have specific needs that facilitate enrollment in HIV-prevention counseling
www.tandfonline.com - 3/5/12
Restricting the use of blood transfusion | Cochrane Summaries
summaries.cochrane.org - 4/18/12
This review compares two injectable hormonal contraceptives containing only progestogen, namely depot medroxyprogesterone acetate (DMPA) and norethisterone oenanthate (NET-EN), for the risks and reasons of their discontinuation and for their clinical effe
summaries.cochrane.org - 4/18/12
The Spectrum of Neuro-AIDS Disorders: Pathophysiology, Diagnosis, and Treatment [Book Reviews]
archneur.ama-assn.org - 2/13/12

 

The AIDS Reader Online Archive »

 

  • HIV and Viral Hepatitis Coinfection

    A 44-year-old man with known HIV infection for more than 20 years presented with fatigue, nausea, and vomiting with a recent weight loss of 40 lb. Read More

  • Fatal HIV-Associated Anaplastic Large-Cell Lymphoma

    A 42-year-old Hispanic man with HIV infection diagnosed 4 years earlier had a recent medical history significant for Mycobacterium avium-intracellulare pneumonia. Read More

  •  

    Parotid Gland Deformities in HIV Seropositive Patients

    Benign lymphoepithelial hypertrophy of the parotid gland is among the head and neck lesions that affect more than half of HIV patients. The condition is poorly recognized and sometimes treated incorrectly, even though an effective therapy has been recognized.. Read More

 

 
FEATURED ARTICLES

The AIDS Reader. Vol. 19 No. 6
Case Report 

Isolated Unilateral Acute Retinal Necrosis Syndrome as the Initial Manifestation of HIV Infection

By Sujit Gharai, MD; Pradeep Venkatesh, MD; Satpal Garg, MD; Surendra K. Sharma, MD; Prapti Ghosh Gharai, MBBS; Rajpal Vohra, MD


Liron Pantanowitz, MD; Bruce J. Dezube, MD--Series Editors | June 5, 2009

Dr S. Gharai is a medical resident and Dr Venkatesh, Dr Garg, and Dr Vohra are professors at the Dr. Rajendra Prasad Centre for Ophthalmic Sciences, New Delhi. Dr Sharma is professor in the department of medicine at the All India Institute of Medical Sciences, New Delhi. Dr P. G. Gharai is a medical resident at the Nilratan Sircar Medical College, Calcutta.


We report a rare case of isolated unilateral acute retinal necrosis syndrome without any history of associated herpes zoster or other conditions attributed to HIV infection as the initial manifestation of HIV infection. A 30-year-old man presented with a history of sudden diminished vision in the right eye with no apparent predisposing factors. Examination revealed right eye acute retinal necrosis. All laboratory test results were normal except the patient tested positive for HIV. This case of an atypical ophthalmic manifestation as initial presentation of HIV infection highlights the need for increased index of suspicion for HIV infection in young patients with acute retinal necrosis syndrome. [AIDS Reader. 2009;19:231-234]


The lifetime cumulative risk of at least 1 abnormal ocular lesion for an HIV-positive person ranges from 52% to 100%. Ophthalmic involvement can occur during the early phase of HIV infection, and ocular lesions are mainly noted in the posterior segment.1,2

The posterior segment manifestations are HIV vasculopathy, infectious retinopathy, choroidopathy, and rare neoplasms. HIV vasculopathy has included HIV microangiopathy and large-vessel disease. HIV microangiopathy is the most common manifestation (40% to 60% of cases) of AIDS in developed countries. Usually, HIV microangiopathy develops when the CD4+ cell count is low (less than 100/µL), but most affected patients usually have no ocular symptoms. Manifestations of HIV microangiopathy include cotton-wool spots, retinal hemorrhages, microaneurysm, telangiectatic vessels, and ischemic maculopathy.1,2

Cytomegalovirus (CMV) retinitis is the most common (15% to 40%) cause of infectious retinopathy in AIDS. CMV retinitis and its complications (eg, immune recovery uveitis, retinal detachment) are the most common causes of visual morbidity.1,2 Other infectious retinopathies include toxoplasmic retinitis, necrotizing herpetic retinopathy (eg, acute retinal necrosis syndrome, progressive outer retinal necrosis), and syphilitic retinitis. Infectious choroidopathy includes Pneumocystis jiroveci choroidopathy, cryptococcal choroidoretinopathy, and mycobacterial choroiditis.1,2

Acute retinal necrosis syndrome occurs most commonly in otherwise healthy patients. In general, patients are not immunocompromised or systemically ill.3 However, this syndrome may demonstrate subclinical immune dysfunction.4

Ocular manifestations may be the presenting sign of a systemic infection in an otherwise asymptomatic HIV-positive person.5 Ocular involvement in these cases is varied and can affect almost all structures of the eye. Most of the visually disabling ocular manifestations, particularly those caused by an opportunistic infection, occur in late-stage HIV disease or AIDS, whereas presumed HIV-related asymptomatic ocular lesions occur in the earlier stages.4,5

Although HIV-infected patients may present with an isolated ophthalmic complication as the initial manifestation of their HIV infection without any other sign of opportunistic infection or condition attributed to HIV infection or indicative of a defect in cell-mediated immunity, HIV infection is relatively less commonly diagnosed by ophthalmologists in its initial presentation. We describe a case of isolated unilateral acute retinal necrosis in a patient as the initial manifestation of his HIV infection, and to the best of our knowledge, this phenomenon has not been previously reported.

CASE SUMMARY
A 30-year-old man presented to our outpatient department with a history of gradual decrease in vision with floaters in the right eye for 1 month. He also had a history of mild pain in his right eye for 2 weeks. There was no history suggestive of adnexal or corneal involvement or of significant dermatological, neurological, or other systemic illness.

On ocular examination, the visual acuity in the right eye was limited to perception of light and the projection of rays was inaccurate; the left eye was 6/6 using the Snellen visual acuity chart. Findings from an examination of ocular adnexa and ocular movement of both eyes were normal. The anterior chamber cell of the right eye was 3+ with fresh keratic precipitates in the cornea, and there was also pigment deposition over the anterior capsule. The anterior chamber of the left eye was normal. Right eye direct and left eye consensual pupillary reflex was absent. Left eye direct and right eye consensual pupillary reflex was present. Intraocular pressures in both eyes were normal (12 mm Hg) by Goldman applanation tonometry.

Figure 1. Fundus photograph of the right eye of a 30-year-old HIV-positive man showing multiple foci of confluent retinal necrosis with discrete borders in the peripheral retina suggestive of acute retinal necrosis syndrome.

In the right eye, dilated fundus examination showed vitreitis (retrolental cell 3+) and concentric confluent areas of retinal necrosis. The areas had discrete borders in the peripheral retina encroaching the posterior pole and accompanied with vascular occlusion and papillitis (pale disc). These features were characteristic of acute retinal necrosis syndrome (Figures 1 and 2). Findings from the dilated fundus examination of the left eye were normal. Detailed systemic evaluation was carried out in consultation with the physician.

The findings from the patient’s physical and dermatological examinations were normal. A Mantoux test showed no induration (anergy). A chest radiograph was normal. Toxoplasma, hepatitis B virus, hepatitis C virus, CMV, herpes simplex virus (HSV), and varicella-zoster virus (VZV) antibody titers were negative. All laboratory test results were negative or within reference (normal) ranges, except he was found to be HIV-positive, and his CD4+ cell count was 129/µL.

Figure 2

Figure 2. Fundus photograph of the right eye of a 30-year-old HIV-positive man showing concentric confluent areas of retinal necrosis encroaching the posterior pole accompanied with occlusive vasculitis and papillitis (pale disc) suggestive of acute retinal necrosis syndrome.

On the basis of the above clinical findings and investigations, right eye acute retinal necrosis syndrome with concurrent HIV infection was diagnosed. A standard twice-daily antiretroviral regimen of lamivudine(Drug information on lamivudine) 150 mg, stavudine(Drug information on stavudine) 30 mg, and nevirapine(Drug information on nevirapine) 200 mg was begun. Intravenous acyclovir (1500 mg/m2 per day in 3 divided doses) was given for 10 days followed by oral acyclovir maintenance (800 mg 5 times daily). On follow-up at 1 year, there was no improvement of vision in his right eye; the retinal lesions were showing resolution, although the disc was still pale (optic atrophy) with retinal arterial narrowing. There was no deterioration of renal function. In addition, there was no retinal detachment in the affected eye, no significant changes in the fellow eye, and no significant systemic or dermatological involvement.

DISCUSSION
Acute retinal necrosis syndrome is a rare disease, and the exact pathological mechanism is not completely understood. It has been postulated to be caused by one of the neurotropic human herpesviruses: HSV (type 1 or 2), VZV, or Epstein-Barr virus. The American Uveitis Society criteria for a diagnosis of acute retinal necrosis include focal, well-demarcated, peripheral areas of retinal necrosis; rapid circumferential progression; occlusive vasculopathy with arteriolar involvement; and a prominent inflammatory reaction in the vitreous and anterior chamber. The diagnosis of acute retinal necrosis syndrome is clinical, and the presence of optic neuropathy, scleritis, and pain supports the diagnosis. The immunological status of the patient does not influence the clinical diagnosis of acute retinal necrosis syndrome.6 The fellow eye becomes involved in about 36% of patients with acute retinal necrosis, usually within 6 weeks of involvement of the first eye.7

Our patient had classic clinical features of unilateral acute retinal necrosis syndrome in the form of panuveitis, vitreitis, and peripheral concentric confluent areas of retinal necrosis encroaching the posterior pole and accompanied with vascular occlusion and optic neuropathy. In patients with HIV infection, acute retinal necrosis tends to be severe and bilateral with a poorer visual prognosis. In these patients, acute retinal necrosis usually involves the posterior pole and optic nerve early,8,9 and their CD4+ cell count is typically above 60/µL. Large retinal holes with retinal detachment occur within 2 months in 25% to 75% of patients with acute retinal necrosis syndrome.1,7-10 Acute retinal necrosis in HIV-positive patients occurs when they are not totally immunosuppressed as opposed to CMV retinitis, which is seen in severely immunosuppressed patients, often with systemic infection.11,12

CMV retinitis, the most common necrotizing retinitis in patients with AIDS, generally occurs in immunocompromised persons with CD4+ cell counts below 50/µL. Unlike that of acute retinal necrosis syndrome, the clinical course of CMV retinitis is chronic and indolent with minimal or absent vitreous inflammation. CMV retinitis manifests initially with 1 or 2 patches of white granular retinal lesions. These lesions are usually distributed near retinal vessels, suggesting a hematogenous spread. Active retinitis occurs adjacent to atrophic areas demonstrating a brush-fire appearance. Hemorrhage is more common with CMV retinitis than with acute retinal necrosis syndrome.1,13

Progressive outer retinal necrosis (PORN) is another variant of herpetic retinitis in patients with AIDS. With PORN, the CD4+ cell count is usually below 50/µL. It is an extremely progressive necrotizing retinitis characterized by an early patchy multifocal, deep outer retinal lesion, often initially in the parafoveal region, with late diffuse thickening of the retina, absence of vascular inflammation, and minimal or no vitreous inflammation. PORN progresses from the posterior pole to involve the peripheral retina, resulting in widespread retinal necrosis and atrophy.

Toxoplasmic chorioretinitis is characterized by diffuse multifocal retinitis and vitreitis. In immunocompromised hosts, it can mimic acute retinal necrosis syndrome. These persons generally present with a primary infection and lack the typical chorioretinal scar seen in immunocompetent patients, which further complicates the diagnosis. Such patients have a more fulminant presentation, which includes dense yellow-white lesions with better-defined granular borders, occasionally with small satellite lesions. Inflammation is usually more intense; retinal hemorrhage occurs less frequently; and vasculitis is more prominent adjacent to areas of necrosis. The peripheral retina is usually less involved in toxoplasmic chorioretinitis than in acute retinal necrosis syndrome.1,13

Treatment of acute retinal necrosis syndrome is complex. Controlled, randomized, prospective treatment studies on acute retinal necrosis syndrome have not been conducted, so current recommendations are solely based on anecdotal data. It has been suggested that early use of antiviral therapy (eg, intravenous acyclovir) before the appearance of confluent lesions greatly speeds regression and delays or prevents hole formation; however, the main advantage of this approach is to prevent involvement of the fellow eye. A systemic corticosteroid can be given 24 to 48 hours after starting intravenous acyclovir therapy to reduce inflammation, but HIV infection should be ruled out before administering a systemic corticosteroid.7 Ando and colleagues14 discovered hyperaggregation of platelets in 6 of 7 patients with bilateral acute retinal necrosis, as determined by adenosine(Drug information on adenosine) diphosphate aggregation testing and measuring the active partial prothrombin time. Aspirin(Drug information on aspirin) combined with systemic corticosteroids was found to normalize this hypercoagulation state.

Acute retinal necrosis syndrome typically occurs in healthy patients and is probably related to an immune dysfunction.3,4 It was first described in an immunocompromised patient in 198511 and has been increasingly observed among persons with HIV infection. Several cases have been reported in HIV-infected patients presenting with acute retinal necrosis syndrome in association with skin manifestations of VZV infection.12 Chess and Marcus9 reported a case of bilateral acute retinal necrosis syndrome associated with unilateral herpes zoster ophthalmicus as the presenting sign of HIV infection.

In our case, a young man presented with right eye acute retinal necrosis syndrome without any history of associated herpes zoster or other conditions associated with HIV infection or indicative of a defect in cell-mediated immunity. In addition, we were not able to find any infectious etiology for acute retinal necrosis syndrome in this patient except for his HIV infection. HIV infection is a hypercoagulable state, and the immune system is continually activated owing to the chronicity of infection and persistence of virus replication. This activated state causes hyperactivation of B cells leading to hypergammaglobulinemia.15 A hypercoagulable state may be related to lupus anticoagulant, clotting abnormalities, elevated levels of tumor necrosis factor-α, and development of immune complexes in the HIV-infected patient. Another possible mechanism for the acute retinal necrosis is a severe hypercoagulable state.14

After extensive search in the published literature (using PubMed), we did not find any report of isolated acute retinal necrosis syndrome as the initial manifestation of HIV infection. This report may be the first report of such a case. HIV-infected patients may present with an isolated atypical ophthalmic complication as the initial manifestation of HIV infection without any other sign of opportunistic infection or other conditions attributed to HIV infection or indicative of a defect in cell-mediated immunity. This case highlights the need for an increased index of suspicion for HIV infection because isolated acute retinal necrosis syndrome may be the presenting sign of HIV infection. In such settings, ophthalmologists may have an important and unique role in the initial screening for and diagnosis of HIV infection.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.





References
1. Vrabec TR. Posterior segment manifestations of HIV/AIDS. Surv Ophthalmol. 2004;49:131-157.
2. Gharai S, Venkatesh P, Garg S, et al. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Ophthalmic Epidemiol. 2008;15:264-271.
3. Kezuka T, Atherton SS. Acute retinal necrosis. Chem Immunol Allergy. 2007;92:244-253.
4. Rochat C, Herbort CP. Acute retinal necrosis syndrome. Lausanne cases, review of the literature and new physiopathogenetic hypothesis [in French]. Klin Monatsbl Augenheilkd. 1994;204:440-449.
5. Gharai S, Venkatesh P, Tandon R, Garg S. Peripheral ulcerative keratitis and central retinal vein occlusion as the initial manifestation of HIV infection. Ocul Immunol Inflamm. 2007;15:407-409.
6. Holland GN. Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. Am J Ophthalmol. 1994;117:663-667.
7. Blumenkranz MS, Culbertson WW, Clarkson JG, Dix R. Treatment of the acute retinal necrosis syndrome with intravenous acyclovir. Ophthalmology. 1986;93:296-300.
8. Matsuo T, Morimoto K, Matsuo N. Factors associated with poor visual outcome in acute retinal necrosis. Br J Ophthalmol. 1991;75:450-454.
9. Chess J, Marcus DM. Zoster-related bilateral acute retinal necrosis syndrome as presenting sign in AIDS. Ann Ophthalmol. 1988;20:431-435, 438.
10. Friberg TR, Jost BF. Acute retinal necrosis in an immunosuppressed patient. Am J Ophthalmol. 1984;98:515-517.
11. Neetens A, Stevens W, Taelman R, et al. Immune deficiency and necrotising retinopathy. Bull Soc Belge Ophtalmol. 1985;215:73-86.
12. Batisse D, Eliaszewicz M, Zazoun L, et al. Acute retinal necrosis in the course of AIDS: study of 26 cases. AIDS. 1996;10:55-60.
13. Chang S, Young LH. Acute retinal necrosis: an overview. Int Ophthalmol Clin. 2007;47:145-154.
14. Ando F, Kato M, Goto S, et al. Platelet function in bilateral acute retinal necrosis. Am J Ophthalmol. 1983;96:27-32.
15. Simon V, Ho DD, Abdool Karim Q. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet. 2006;368:489-504.

 
IMAGES IN AIDS/HIV

Parotid Gland Deformities in HIV Seropositive Patients: The Best Choice for Cosmetic Control
April 9, 2012

More than half of people with HIV infection in the United States develop head and neck lesions. Common among these is enlargement of the parotid gland, which causes disfigurement and therefore distress. This review discusses the evidence for radiation treatment as the best option, as well as the dangers of choosing the wrong treatment for this benign comorbidity of HIV-positive status.

HIV-Positive Male Presents With Multiple Symptoms and Has a History of Colonic Polyps
December 19, 2011

A 20-year-old HIV positive male presents with headache, nausea, and vomiting following a seizure. History is notable for 3 surgeries to remove colonic polyps. Subsequent MRI brain scan with contrast reveals a mass in the left frontal lobe which is removed. The image above is an H&E stained section of the mass.

Severe Psoriasis in Advanced HIV Infection
February 3, 2010

A 50-year-old African American man with HIV infection had a CD4+ T-cell count of 18/μL (1%), CD8+ cell count of 1035/μL (69%), and CD4:CD8 ratio of 0.01 at the time of diagnosis. He had multiple erythematosquamous skin lesions over his forehead, face, chest, back, and extremities

Keloid After Herpes Zoster in an HIV-Infected Person
May 11, 2009

Herpes zoster, or shingles, is characterized by unilateral radicular pain and a vesicular rash that is generally limited to a single dermatome. It results from reactivation of latent varicella-zoster virus (VZV) within the sensory ganglia.

 
MEDLINE
Functional characterization of a human cyclin T1 mutant reveals a different binding surface for Tat and HEXIM1.
pubmed.gov - 5/10/12
HIV transcription is regulated at the step of elongation by the viral Tat protein and the cellular positive transcription elongation factor b (P-TEFb; Cdk9/cyclin T1). Herein, a human cyclin T1 mutant, cyclin T1-U7, which contains four substitutions and one deletion in the N-terminal cyclin box, was stably expressed in HeLa cells. HIV transcription was efficiently inhibited in HeLa-HA-CycT1-U7 stable cells. Cyclin T1-U7 bound Tat but did not modulate its expression levels, which remained high. Importantly cyclin T1-U7 failed to interact with Cdk9 or HEXIM1 and did not interfere with endogenous P-TEFb activity to stimulate MEF2C or NFkB mediated transcription. In a T cell line and primary CD4+ cells, cyclin T1-U7 also inhibited HIV transcription. We conclude that cyclin T1-U7 sequesters Tat from P-TEFb and inhibits HIV transcription. Importantly, N-terminal residues in cyclin T1 are specifically involved in the binding of cyclin T1 to HEXIM1 but not to Tat.
A role for granulocyte-macrophage colony-stimulating factor in the regulation of CD8(+) T cell responses to rabies virus.
pubmed.gov - 5/10/12
Inflammatory cytokines have a significant role in altering the innate and adaptive arms of immune responses. Here, we analyzed the effect of GM-CSF on a RABV-vaccine vector co-expressing HIV-1 Gag. To this end, we immunized mice with RABV expressing HIV-1 Gag and GM-CSF and analyzed the primary and recall CD8(+) T cell responses. We observed a statistically significant increase in antigen presenting cells (APCs) in the spleen and draining lymph nodes in response to GM-CSF. Despite the increase in APCs, the primary and memory anti HIV-1 CD8(+) T cell response was significantly lower. This was partly likely due to lower levels of proliferation in the spleen. Animals treated with GM-CSF neutralizing antibodies restored the CD8(+) T cell response. These data define a role of GM-CSF expression, in the regulation of the CD8(+) T cell immune responses against RABV and has implications in the use of GM-CSF as a molecular adjuvant in vaccine development.
MuLV IN mutants responsive to HDAC inhibitors enhance transcription from unintegrated retroviral DNA.
pubmed.gov - 5/10/12
For Moloney murine leukemia virus (M-MuLV), sustained viral infections require expression from an integrated provirus. For many applications, non-integrating retroviral vectors have been utilized to avoid the unwanted effects of integration, however, the level of expression from unintegrated DNA is significantly less than that of integrated provirus. We find that unintegrated DNA expression can be increased in the presence of HDAC inhibitors, such as TSA, when applied in combination with integrase (IN) mutations. These mutants include an active site mutation as well as catalytically active INs bearing mutations of K376 in the MuLV C-terminal domain of IN. MuLV IN K376 is homologous to K266 in HIV-1 IN, a known substrate for acetylation. The MuLV IN protein is acetylated by p300 in vitro, however, the effect of HDAC inhibitors on gene expression from unintegrated DNA is not dependent on the acetylation state of MuLV IN K376.
Research highlights.
pubmed.gov - 5/2/12
TNF-Related Apoptosis-Inducing Ligand 129618-40-2 Nevirapine EC 2.7.7.49 HIV Reverse Transcriptase EC 3.4.22.- Caspases IM drug effects metabolism drug effects pharmacology pharmacology physiology
Novel structures of self-associating stapled peptides.
pubmed.gov - 5/2/12
Hydrocarbon stapling of peptides is a powerful technique to transform linear peptides into cell-permeable helical structures that can bind to specific biological targets. In this study, we have used high resolution solution NMR techniques complemented by dynamic light scattering to characterize extensively a family of hydrocarbon stapled peptides with known inhibitory activity against HIV-1 capsid assembly to evaluate the various factors that modulate activity. The helical peptides share a common binding motif but differ in charge, the length, and position of the staple. An important outcome of the study was to show the peptides, share a propensity to self-associate into organized polymeric structures mediated predominantly by hydrophobic interactions between the olefinic chain and the aromatic side-chains from the peptide. We have also investigated in detail the structural significance of the length and position of the staple, and of olefinic bond isomerization in stabilizing the
More Results
 
CLINICAL TRIALS
The Effects of Illnesses on HIV Levels in the Body
www.clinicaltrials.gov - 11/2/12
A Study of 1592U89 in HIV-Infected Adults
www.clinicaltrials.gov - 11/2/12
A Study of Two Anti-HIV Drug Combinations in HIV-Infected Patients
www.clinicaltrials.gov - 11/2/12
More Results


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Sweet Syndrome and Syphilis in an HIV-Infected Person
  • The Changing Face of Anal Cancer
  • Extensive Development of Flat Warts as a Cutaneous Manifestation of Immune Reconstitution Syndrome
  • Establishing an Anal Dysplasia Clinic for HIV-Infected Men: Initial Experience
  • Multicentric Castleman Disease, Kaposi Sarcoma, Hemophagocytic Syndrome, and a Novel HHV8-Lymphoproliferative Disorder
  • Ryan White: An Unintentional Home Builder
  • Antiretroviral Therapy: Short-Term, Earlier Interventions Show Promise
  • Update on HIV in Children and Adolescents
  • Parotid Gland Deformities in HIV Seropositive Patients: The Best Choice for Cosmetic Control
  • HIV and Older Adults: A Growing Population
  • Breast-fed Antiretrovirals Block Infant HIV
  • Podcast: Gene Tests Can Make Abacavir Safe for AIDS Treatment
  • Antiretroviral Therapy: Short-Term, Earlier Interventions Show Promise
  • Update on HIV in Children and Adolescents
Click here to subscribe to our newsletter


 
PRACTICE GUIDELINES
National Guideline Clearinghouse | Cognitive disorders and HIV/AIDS: HIV-associated dementia and delirium.
www.guidelines.gov -
National Guideline Clearinghouse | Suicidality and violence in patients with HIV/AIDS.
www.guidelines.gov -
National Guideline Clearinghouse | Depression and mania in patients with HIV/AIDS.
www.guidelines.gov -
National Guideline Clearinghouse | HIV/AIDS evidence-based nutrition practice guideline.
www.guidelines.gov -
National Guideline Clearinghouse | Adapting your practice: treatment and recommendations for homeless patients with HIV/AIDS.
www.guidelines.gov -
rccm200605587st 912..927
www.thoracic.org -
Thomson
www.naspghan.org -
L'amniocentse chez les femmes infectes par l'hpatite B, L'hpatite C ou le virus de L'immunodficience humaine
www.sogc.org -
www.acponline.org/clinical_information/resources/end_of_life_care/cultural_eol.pdf
www.acponline.org -
RR5211-Front Cover-TB.pmd
www.thoracic.org -
More Results
 
INFORMATION FROM AIDS.gov BLOG
A Day to Act on HIV and Viral Hepatitis in the Asian and Pacific Islander Community
AIDS.gov Blog - 5/18/12
Tomorrow (May 19) our Nation marks the eighth annual National Asian and Pacific Islander HIV/AIDS Awareness Day and the first–ever National Hepatitis Testing Day. Both observances represent “calls to action” for the country and hold special meaning for me. As an Asian American physician, I have cared for many individuals living with HIV and/or hepatitis....
General Information Guide Now Available to Help You Navigate AIDS 2012
AIDS.gov Blog - 5/17/12
With over 20,000 participants and more than 250 sessions, you may be starting to wonder how you will navigate AIDS 2012. This week, conference organizers released the General Information Guide  to help you with your planning. The Guide contains a wealth of practical information, including details about on-site registration and check-in, a convention center map,...
More Results


 
FROM PHYSICIANS PRACTICE
Physician Performance Goals Are Great, But Balance Is More Realistic
Jennifer Frank, MD,  May 15, 2012
Performance measurements for physicians are well-intentioned and get me to rethink how I practice. But in the end I won't make the goals, so I'll have to go with balance over perfection.
Designing the Perfect Business Card for Your Medical Practice
C. Noel Henley, MD,  May 11, 2012
Does your business card say anything substantive about the valuable work you do in your practice? Here’s how to re-design your next business card for maximum impact and engagement.
Registered Nurses an Ideal Fit for Primary Care Practices
Audrey "Christie" McLaughlin, RN,  May 10, 2012
Here are four good reasons to hire a registered nurse for your primary care practice …maybe even instead of a medical assistant.
The Five Biggest Medical Practice Marketing Mistakes
James Doulgeris,  May 10, 2012
There are best practices to marketing your practice, but often, success is more about knowing what not to do. Here are the five most common pitfalls …and how to avoid them.
Can You Practice Medicine and Manage Your Practice?
Rosemarie Nelson,  May 9, 2012
Whether you practice alone, or in a group, if you're trying to see patients in this pay-for-volume environment and also run the business of your practice, you may be missing out on important opportunities.

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2012 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy